PENPULIMAB

PENPULIMAB was reported 98 times

PENPULIMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 REACTIVE CAPILLARY ENDOTHELIAL PROLIFERATION 1 0.0182
1 SKIN HYPERPLASIA 1 0.0175
2 LEIOMYOSARCOMA METASTATIC 1 0.0147
3 ENDOCRINE TOXICITY 1 0.0098
4 OXYGEN SATURATION IMMEASURABLE 1 0.0091
5 DERMATOCHALASIS 1 0.0068
6 MUSCULOSKELETAL TOXICITY 1 0.0054
7 URINARY OCCULT BLOOD POSITIVE 1 0.0043
8 THYROIDITIS SUBACUTE 1 0.0034
9 POST PROCEDURAL PNEUMONIA 1 0.0033
10 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 1 0.0026
11 RADIATION OESOPHAGITIS 1 0.0026
12 CAPILLARY DISORDER 1 0.0026
13 TRI-IODOTHYRONINE INCREASED 1 0.0025
14 HAEMANGIOMA OF SKIN 1 0.0023
15 IMMUNE-MEDIATED HYPOPHYSITIS 1 0.0022
16 HYPOPHYSITIS 3 0.0015
17 THYROXINE INCREASED 1 0.0014
18 IMMUNE-MEDIATED MYOCARDITIS 2 0.0012
19 TRANSFUSION REACTION 1 0.0011
20 HYPERPLASIA 1 0.0011
21 OCULAR TOXICITY 1 0.0009
22 MYOCARDIAL INJURY 1 0.0009
23 HYPOTHALAMO-PITUITARY DISORDER 1 0.0007
24 IMMUNE-MEDIATED LUNG DISEASE 1 0.0005
25 IMMUNE-MEDIATED ENTEROCOLITIS 2 0.0005
26 OTOTOXICITY 1 0.0005
27 ADENOCARCINOMA OF COLON 1 0.0005
28 MYOCARDITIS 6 0.0005
29 ADRENAL DISORDER 1 0.0005
30 CARDIAC DISCOMFORT 1 0.0005
31 FOAMING AT MOUTH 1 0.0005
32 ABDOMINAL INFECTION 1 0.0004
33 HYPOALBUMINAEMIA 3 0.0004
34 MYASTHENIA GRAVIS 3 0.0004
35 IMMUNE-MEDIATED MYOSITIS 1 0.0004
36 MYELOSUPPRESSION 13 0.0004
37 ANAPHYLACTIC SHOCK 9 0.0003
38 HYPOTHYROIDISM 10 0.0003
39 SKIN INJURY 1 0.0003
40 REGURGITATION 1 0.0003
41 NEUROTOXICITY 5 0.0003
42 PAPULE 2 0.0003
43 CARDIAC DYSFUNCTION 1 0.0003
44 PROTEINURIA 5 0.0003
45 THYROID DISORDER 4 0.0003
46 ADRENAL INSUFFICIENCY 3 0.0002
47 HEPATIC FUNCTION ABNORMAL 9 0.0002
48 PNEUMONITIS 6 0.0002
49 IMMUNE THROMBOCYTOPENIA 1 0.0002
50 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 5 0.0002
51 HAEMATOTOXICITY 2 0.0002
52 GASTROINTESTINAL TOXICITY 1 0.0002
53 HYPERTHYROIDISM 3 0.0002
54 PROTEIN URINE PRESENT 1 0.0002
55 LEUKOPENIA 10 0.0002
56 DERMATITIS EXFOLIATIVE 1 0.0002
57 APLASTIC ANAEMIA 1 0.0002
58 DRUG-INDUCED LIVER INJURY 6 0.0002
59 OESOPHAGITIS 2 0.0002
60 NEPHROPATHY TOXIC 2 0.0002
61 SKIN TOXICITY 1 0.0002
62 GRANULOCYTOPENIA 1 0.0002
63 ELECTROLYTE IMBALANCE 2 0.0002
64 SKIN WARM 1 0.0002
65 TYPE 1 DIABETES MELLITUS 1 0.0002
66 LIVER INJURY 4 0.0002
67 DERMATITIS ALLERGIC 2 0.0002
68 ENTERITIS 1 0.0002
69 BLOOD BILIRUBIN INCREASED 4 0.0001
70 TACHYPNOEA 2 0.0001
71 PULMONARY TOXICITY 1 0.0001
72 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 1 0.0001
73 METASTASES TO BONE 2 0.0001
74 EMBOLISM 1 0.0001
75 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
76 ASPARTATE AMINOTRANSFERASE INCREASED 6 0.0001
77 DRUG ERUPTION 2 0.0001
78 CARDIOTOXICITY 1 0.0001
79 HAEMOLYTIC ANAEMIA 1 0.0001
80 GASTROINTESTINAL INFECTION 1 0.0001
81 MYOSITIS 1 0.0001
82 ALANINE AMINOTRANSFERASE INCREASED 6 0.0001
83 HYPERBILIRUBINAEMIA 1 0.0001
84 DERMATITIS 2 0.0001
85 TRANSAMINASES INCREASED 2 0.0001
86 NERVE INJURY 1 0.0001
87 HEPATOTOXICITY 2 0.0001
88 THROMBOCYTOPENIA 10 0.0001
89 SPINAL PAIN 1 0.0001
90 HYPERGLYCAEMIA 3 0.0001
91 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
92 ILEUS 1 0.0001
93 CHEST DISCOMFORT 8 0.0001
94 OXYGEN SATURATION DECREASED 4 0.0001
95 SKIN REACTION 1 0.0001
96 SINUS TACHYCARDIA 1 0.0001
97 ANAEMIA 13 0.0001
98 LYMPHOMA 1 0.0001
99 THERAPY PARTIAL RESPONDER 1 0.0001
100 CYSTITIS 2 0.0001
101 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
102 ORTHOSTATIC HYPOTENSION 1 0.0001
103 METASTASES TO LIVER 1 0.0001
104 NEUTROPHIL COUNT DECREASED 2 0.0000
105 PRODUCT PRESCRIBING ISSUE 1 0.0000
106 MELAENA 1 0.0000
107 RASH MACULO-PAPULAR 1 0.0000
108 NEUTROPENIA 6 0.0000
109 SHOCK 1 0.0000
110 MUSCLE TWITCHING 1 0.0000
111 RASH ERYTHEMATOUS 2 0.0000
112 BLOOD PRESSURE FLUCTUATION 1 0.0000
113 INTERSTITIAL LUNG DISEASE 2 0.0000
114 SKIN ULCER 1 0.0000
115 MUCOSAL INFLAMMATION 1 0.0000
116 PANCREATITIS 2 0.0000
117 URINARY INCONTINENCE 1 0.0000
118 HEPATIC FAILURE 1 0.0000
119 HYPERHIDROSIS 4 0.0000
120 LIP SWELLING 1 0.0000
121 FLUSHING 3 0.0000
122 NEOPLASM PROGRESSION 1 0.0000
123 RESPIRATORY FAILURE 2 0.0000
124 INTESTINAL OBSTRUCTION 1 0.0000
125 COLITIS 1 0.0000
126 RASH 11 0.0000
127 CARDIAC FAILURE 2 0.0000
128 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
129 RENAL IMPAIRMENT 2 0.0000
130 OSTEOARTHRITIS 1 0.0000
131 GASTROINTESTINAL DISORDER 2 0.0000
132 HYPOKALAEMIA 1 0.0000
133 DECREASED APPETITE 5 0.0000
134 ARRHYTHMIA 1 0.0000
135 NEUROPATHY PERIPHERAL 2 0.0000
136 PRODUCTIVE COUGH 1 0.0000
137 PYREXIA 7 0.0000
138 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
139 HYPERTENSION 4 0.0000
140 PLATELET COUNT DECREASED 2 0.0000
141 RASH PRURITIC 1 0.0000
142 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
143 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
144 PRURITUS 7 0.0000
145 HAEMATOCHEZIA 1 0.0000
146 HYPONATRAEMIA 1 0.0000
147 HERPES ZOSTER 1 0.0000
148 DYSPHONIA 1 0.0000
149 PALPITATIONS 2 0.0000
150 VOMITING 8 0.0000
151 IRRITABILITY 1 0.0000
152 STOMATITIS 1 0.0000
153 PLEURAL EFFUSION 1 0.0000
154 DISCOMFORT 1 0.0000
155 BLOOD CREATININE INCREASED 1 0.0000
156 INFUSION RELATED REACTION 1 0.0000
157 HEPATIC ENZYME INCREASED 1 0.0000
158 ERYTHEMA 3 0.0000
159 DIARRHOEA 9 0.0000
160 CONSTIPATION 3 0.0000
161 ASTHENIA 5 0.0000
162 DIABETES MELLITUS 1 0.0000
163 NAUSEA 10 0.0000
164 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
165 PNEUMONIA 4 0.0000
166 TREATMENT FAILURE 1 0.0000
167 MYALGIA 2 0.0000
168 TACHYCARDIA 1 0.0000
169 PULMONARY EMBOLISM 1 0.0000
170 DRUG INTOLERANCE 1 0.0000
171 ATRIAL FIBRILLATION 1 0.0000
172 HEART RATE INCREASED 1 0.0000
173 ABDOMINAL DISTENSION 1 0.0000
174 MUSCULAR WEAKNESS 1 0.0000
175 ABDOMINAL PAIN 2 0.0000
176 LOSS OF CONSCIOUSNESS 1 0.0000
177 FATIGUE 6 0.0000
178 RENAL FAILURE 1 0.0000
179 VISION BLURRED 1 0.0000
180 HYPOAESTHESIA 1 0.0000
181 BLOOD PRESSURE INCREASED 1 0.0000
182 URTICARIA 1 0.0000
183 ABDOMINAL DISCOMFORT 1 0.0000
184 OFF LABEL USE 5 0.0000
185 DYSPNOEA 3 0.0000
186 GAIT DISTURBANCE 1 0.0000
187 HYPOTENSION 1 0.0000
188 DIZZINESS 2 0.0000
189 WEIGHT DECREASED 1 0.0000
190 DEATH 3 0.0000
191 ARTHRALGIA 1 0.0000
192 DRUG INEFFECTIVE 2 0.0000